Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects
Reviews in Cardiovascular Medicine · 28.07.2025 · 26 (7)
DOI: 10.31083/rcm38407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 28.07.2025. Verfasst von Dongda Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure is a complex pathological condition characterized by various mechanisms of cellular death, among which programmed cell death (PCD) plays a crucial role in the pathophysiology of cardiac dysfunction. This review delves into the different forms of PCD present in heart failure, including apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis, and examines the mechanisms of action involved and the potential therapeutic targets for treating cardiac failure. By analyzing the latest research findings, we reveal the pivotal role of PCD in the progression of heart failure and discuss the preclinical prospects of intervening in these processes to develop novel therapeutic strategies. For instance, pharmacological agents that inhibit receptor-interacting protein kinases (RIPK1 and RIPK3) involved in necroptosis have been demonstrated to reduce cardiac injury and improve functional outcomes. Additionally, targeting the inflammatory responses associated with necrotic cell death, such as using interleukin (IL)-1β inhibitors, may provide a dual benefit by reducing cell death and inflammation. Thus, combining current knowledge will enhance our understanding in this field and promote innovative approaches to managing heart failure more effectively.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China.
- People's Hospital of Ningxiang City, Hunan University of Chinese Medicine, 410600 Changsha, Hunan, China.
ORCID-Profile: Donghong Deng, Biao Tang
Zitieren
APA
Wu, D., Deng, D., & Tang, B. (2025). Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects. Reviews in Cardiovascular Medicine, 26(7). https://doi.org/10.31083/rcm38407
Vancouver
Wu D, Deng D, Tang B. Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects. Reviews in Cardiovascular Medicine. 2025;26(7). doi:10.31083/rcm38407
BibTeX
@article{Wu2025,
author = {Wu, Dongda and Deng, Donghong and Tang, Biao},
title = {Programmed Cell Death in Heart Failure: Mechanisms, Impacts, and Therapeutic Prospects},
journal = {Reviews in Cardiovascular Medicine},
year = {2025},
volume = {26},
number = {7},
doi = {10.31083/rcm38407}
}
EUVIMED